We are looking for wound care experts (m/f/d)

for home care visits in the context of a clinical trial.

Job profile

Type of employment: Preferably a fixed-term position at Asklepios Klinik Wandsbek. A freelance arrangement is also possible.
Activity: Independent execution of daily dressing changes and wound treatment, accompanied by precise and comprehensive documentation.
Location: Initial treatment at Asklepios Wandsbek followed by home visits in the north-east of Hamburg.
Employment level:Preferably full time. Part time is possible from a minimum of 60 percent.
Remuneration: In accordance with TVöD-K plus a mobility allowance. For freelance work, remuneration is open to negotiation.
Start: Desired start in February or March 2026. Planned trial period: April 2026 to September 2027.

Requirements & qualifications

Training: Completed qualification as a nurse, nursing specialist, nursing professional, or an equivalent credential.
Further training: Certified wound expert (ICW).
Experience: Proven practical experience and solid expertise in the field of wound care.
Soft skills: Strong patient focus, empathy, and enthusiasm for working with people.
Other: High level of mobility, reliability, and flexibility.

Note: Good Clinical Practice (GCP) training and clinical trial protocol training are required. Both can be completed free of charge during the preparation phase for the trial.

What we offer

Competitive remuneration

according to TVöD-K plus a mobility allowance. For the freelance model, negotiable.

Innovative research

Participation in one of the most promising therapeutic approaches to combat Pseudomonas.

Dynamic team

Integration into an experienced and dedicated team of doctors and wound experts.

Many further benefits

such as workplace health promotion and subsidies for pension provision and for the Deutschlandticket.

The clinical trial

Key data of the planned clinical trial with the investigational medicinal product PB-TX-01

Objective
Test the safety and efficacy of the new medicine PB-TX-01.

Patients
Patients with chronic wounds colonized with P. aeruginosa.

Time period
Expected from early April 2026 to mid-2027.

Participants
90 patients in two groups (test group and control group) of 45 people each.

Duration
90 days per patient, including 14 days of treatment phase at the patient’s home.

Tasks
Daily dressing changes, bacterial swabs, photo documentation & treatment.

Media coverage

When wounds refuse to heal: New clinical trial at the Asklepios Clinic Wandsbek relies on innovative active ingredient

A new clinical trial for the treatment of chronic wounds has been launched at the Asklepios Clinic Wandsbek (Hamburg): The active ingredient PB-TX-01 from the pharmaceutical company PathoBlock is being investigated, which is designed to prevent the adhesion of bacteria – particularly multi-resistant pathogens – to human cells and thus improve wound healing.

Read the full article on asklepios.com (in German)